Insider Transactions in Q4 2021 at I Teos Therapeutics, Inc. (ITOS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
15,671
-0.5%
|
-
|
|
Nov 17
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
15,671
-0.5%
|
-
|
|
Nov 17
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
15,671
-0.31%
|
-
|
|
Nov 03
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,085
-7.37%
|
$170,380
$28.89 P/Share
|
|
Nov 02
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,391
-14.85%
|
$402,948
$28.41 P/Share
|
|
Nov 01
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
81
-0.08%
|
$2,268
$28.0 P/Share
|
|
Oct 21
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
196
-0.2%
|
$5,488
$28.0 P/Share
|
|
Oct 19
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
201
-0.21%
|
$5,628
$28.0 P/Share
|
|
Oct 18
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,167
-0.2%
|
$166,509
$27.14 P/Share
|
|
Oct 18
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,167
-0.2%
|
$166,509
$27.14 P/Share
|
|
Oct 18
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,320
-0.2%
|
$278,640
$27.14 P/Share
|
|
Oct 15
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,635
-1.65%
|
$45,780
$28.01 P/Share
|
|
Oct 15
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,932
-0.17%
|
$295,164
$27.77 P/Share
|
|
Oct 15
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,932
-0.17%
|
$295,164
$27.77 P/Share
|
|
Oct 15
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,295
-0.18%
|
$493,965
$27.77 P/Share
|
|
Oct 14
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
27,320
-0.86%
|
$737,640
$27.3 P/Share
|
|
Oct 14
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
27,320
-0.86%
|
$737,640
$27.3 P/Share
|
|
Oct 14
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
45,719
-0.88%
|
$1,234,413
$27.3 P/Share
|
|
Oct 13
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,929
-0.65%
|
$565,083
$27.13 P/Share
|
|
Oct 13
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,929
-0.65%
|
$565,083
$27.13 P/Share
|
|
Oct 13
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,023
-0.67%
|
$945,621
$27.13 P/Share
|
|
Oct 12
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,521
-0.27%
|
$230,067
$27.09 P/Share
|
|
Oct 12
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,521
-0.27%
|
$230,067
$27.09 P/Share
|
|
Oct 12
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,260
-0.27%
|
$385,020
$27.09 P/Share
|
|
Oct 11
2021
|
Matthew Gall Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,429
+42.62%
|
$86,574
$6.16 P/Share
|
|
Oct 11
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
48,812
-1.5%
|
$1,317,924
$27.24 P/Share
|
|
Oct 11
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
48,812
-1.5%
|
$1,317,924
$27.24 P/Share
|
|
Oct 11
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
81,684
-1.53%
|
$2,205,468
$27.24 P/Share
|
|
Oct 08
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,032
-0.06%
|
$54,864
$27.01 P/Share
|
|
Oct 08
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,032
-0.06%
|
$54,864
$27.01 P/Share
|
|
Oct 08
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,400
-0.06%
|
$91,800
$27.01 P/Share
|
|
Oct 07
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,149
-0.04%
|
$31,023
$27.0 P/Share
|
|
Oct 07
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,149
-0.04%
|
$31,023
$27.0 P/Share
|
|
Oct 07
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,922
-0.04%
|
$51,894
$27.0 P/Share
|
|
Oct 04
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,711
-0.63%
|
$559,197
$27.06 P/Share
|
|
Oct 04
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,711
-0.63%
|
$559,197
$27.06 P/Share
|
|
Oct 04
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
34,659
-0.64%
|
$935,793
$27.06 P/Share
|
|
Oct 01
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,855
-0.21%
|
$185,085
$27.0 P/Share
|
|
Oct 01
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,855
-0.21%
|
$185,085
$27.0 P/Share
|
|
Oct 01
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,471
-0.21%
|
$309,717
$27.0 P/Share
|